Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance
about
Mass drug administration for malariaCommunity engagement and population coverage in mass anti-malarial administrations: a systematic literature review.Transmission-blocking strategies: the roadmap from laboratory bench to the communityEthics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populationsPrevention of Malaria Resurgence in Greece through the Association of Mass Drug Administration (MDA) to Immigrants from Malaria-Endemic Regions and Standard Control MeasuresOptimal Population-Level Infection Detection Strategies for Malaria Control and Elimination in a Spatial Model of Malaria TransmissionMalaria Elimination Campaigns in the Lake Kariba Region of Zambia: A Spatial Dynamical ModelSpatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013.Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage.Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trialEffectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study.Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling studyMonitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workersA review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionTowards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approachPrevention measures and socio-economic development result in a decrease in malaria in Hainan, ChinaThe diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment.Modeling malaria infection and immunity against variant surface antigens in Príncipe Island, West Africa.Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.Malaria eradication and elimination: views on how to translate a vision into realityElimination of Plasmodium falciparum in an area of multi-drug resistance.An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaIn Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparumDisease elimination and re-emergence in differential-equation models.G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.The metabolism of primaquine to its active metabolite is dependent on CYP 2D6Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.Spatial distribution of G6PD deficiency variants across malaria-endemic regions.Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China.Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination.A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia.Evolution from double to triple-antimalarial drug combinations.Children who have received no routine polio vaccines in Nigeria: Who are they and where do they live?Focal Screening to Identify the Subpatent Parasite Reservoir in an Area of Low and Heterogeneous Transmission in the Kenya Highlands.Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment.
P2860
Q24201881-C495F0CC-6633-4923-BDC0-6F167A3EC035Q28074520-3DDA27E6-B3CB-4482-86EA-4A46A5E07C17Q28078982-A0C4756D-22AD-4033-A402-AFADE730BD8EQ28542069-5C1E8A4C-65E3-442B-8DA8-4FF3FFD33886Q28551054-CBE43C63-45A7-4FD0-B834-5C715B13B79AQ28552473-BEE9442C-B9F3-463E-B0EC-0487BE596CBCQ28553680-7E5CBD30-21E6-4110-AA91-CDD101A40428Q30660664-6A4C0FAF-903F-42CA-BAA2-9B4BD241446CQ33626090-1B113009-C9F2-468F-87C6-EE6964C4B106Q33709109-DC2E169E-E984-487B-88A6-1D522CB1CF5AQ33776505-89DD3AF5-7C75-4EED-AA82-216AA68BFC87Q33791653-3C938D03-56E8-4D7A-BFEA-5D8871292FE2Q33794662-0436FC8C-2E5F-467F-A9DA-49E93468B3E4Q33960088-24DAF97E-E1A2-43E4-B1D4-6706573B8934Q34020818-EB5D0F01-C1AA-452B-9924-7C96478090BAQ34023865-2BA300DD-D64E-470A-99FA-A74440BBBAE8Q34254109-37C5BCA7-4C7D-4D0E-BC9F-E398FAC05C2AQ34316859-79F996A7-1336-4C95-AA50-E02C4C16C0D0Q35092698-12057FC3-6397-414E-BC73-C7506F3E9FA3Q35224221-C0610AAD-8F62-47D7-9E7E-B3740A97E052Q35655782-085047C0-2320-49B7-96C7-9A26DADDA073Q35712522-D20B0E99-2784-479E-8993-49B1A8FAC956Q35957194-7BD478F8-719D-457B-9798-2DD7B8E2C664Q36175374-ED5079A4-23F1-4697-B6E9-AA11F060B319Q36290632-A8C67198-6016-4430-A570-3DB3EF370663Q36307040-B39CA49F-86FE-494C-8172-9734FE2EA7F4Q36898157-91D01A2B-5CE9-4174-B7BC-C0A687A76B56Q36945581-FBB6EBE2-9DED-4057-9E43-632866DEA74AQ37205700-29133C40-50C6-4372-A806-C0E76CF79A65Q37228415-F28C7D7C-0B93-4027-910F-7E9B19BA6A6AQ37329332-EFBD3E54-AFDD-47A2-83CD-077B1C8826EAQ37348028-73B38B16-AF18-4898-8BCD-077031D37039Q37485056-E355CB59-C12D-404C-886E-0B982323FEEDQ37509562-25C911F7-B38B-4E50-83DC-5B212C7A171AQ37560634-6C3395B2-5DED-4C6E-AFAF-ABB8FC089B85Q37615926-CAE00851-7377-493A-896E-AD6F91330A33Q38303998-74640F04-90CF-426C-B885-5A0CC8349F85Q38849835-21A362BE-A345-4ACD-8D44-10B4D872F1AAQ39493802-ACB23096-B74D-40FC-8D37-217D90FD0FEBQ40081071-9A09460C-A42B-4A47-8B12-A9031B441422
P2860
Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Optimising strategies for Plas ...... ion and artemisinin resistance
@ast
Optimising strategies for Plas ...... ion and artemisinin resistance
@en
Optimising strategies for Plas ...... ion and artemisinin resistance
@nl
type
label
Optimising strategies for Plas ...... ion and artemisinin resistance
@ast
Optimising strategies for Plas ...... ion and artemisinin resistance
@en
Optimising strategies for Plas ...... ion and artemisinin resistance
@nl
prefLabel
Optimising strategies for Plas ...... ion and artemisinin resistance
@ast
Optimising strategies for Plas ...... ion and artemisinin resistance
@en
Optimising strategies for Plas ...... ion and artemisinin resistance
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Optimising strategies for Plas ...... ion and artemisinin resistance
@en
P2093
Duong Socheat
Guoqiao Li
Jianping Song
Lisa J White
Preap Saroth
Shunmay Yeung
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0037166
P407
P577
2012-01-01T00:00:00Z